HIGH

Glenmark Pharmaceuticals Recalls Carvedilol Tablets Due to Impurity Risk

Glenmark Pharmaceuticals recalled 17,496 bottles of Carvedilol Tablets on August 6, 2025. Tests revealed N-Nitroso Carvedilol Impurity-1 levels exceeded FDA limits. Consumers should stop using the medication immediately.

Quick Facts at a Glance

Recall Date
August 6, 2025
Hazard Level
HIGH
Brands
Glenmark Pharmaceuticals Inc., USA, CARVEDILOL
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter

Product Details

The recall affects Carvedilol Tablets, USP, 12.5 mg, packaged in cartons of 500 tablets. The affected lot numbers are 17241257, 17241258, and 17241279, with an expiration date of June 2026. The product was distributed nationwide in the USA.

The Hazard

The recall stems from CGMP deviations that resulted in N-Nitroso Carvedilol Impurity-1 levels above the FDA-recommended limit of no more than 4.0 ppm. This impurity is a potential health risk.

Reported Incidents

There have been no reported injuries or deaths associated with this recall. The impurity issue is classified as a significant concern due to the potential health effects of long-term exposure.

What to Do

Stop using the recalled Carvedilol Tablets immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for further guidance and potential alternatives.

Contact Information

For more information, consumers can visit the FDA recall notice at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0587-2025 or call Glenmark Pharmaceuticals Inc.

Key Facts

  • Recall date: August 6, 2025
  • Quantity recalled: 17,496 bottles
  • Manufactured in Madhya Pradesh, India
  • Class II recall due to impurity levels
  • Impurity exceeds FDA limit of 4.0 ppm

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #: 17241257
17241258
17241279
Exp. Date 06/2026
UPC Codes
68462-162
68462-163
68462-164
+11 more
Affected States
ALL
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more